Pharma-Bio Serv, Inc.
PBSVDrugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
RPH-104 80 mg | Phase 2 | Acute ST Segment Elevation Myocardial Infarction | - | - |
Frequently asked questions
What is in Pharma-Bio Serv, Inc.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in Pharma-Bio Serv, Inc.'s (PBSV) pipeline across Phase 2. Its lead program is RPH-104 80 mg (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Pharma-Bio Serv, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Pharma-Bio Serv, Inc. (PBSV) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track PBSV biotech catalysts?→
Add PBSV to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Pharma-Bio Serv, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.